Jonathan Colasanti

1.7k total citations
69 papers, 897 citations indexed

About

Jonathan Colasanti is a scholar working on Infectious Diseases, Epidemiology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Jonathan Colasanti has authored 69 papers receiving a total of 897 indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Infectious Diseases, 45 papers in Epidemiology and 17 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Jonathan Colasanti's work include HIV/AIDS Research and Interventions (47 papers), HIV, Drug Use, Sexual Risk (37 papers) and Opioid Use Disorder Treatment (16 papers). Jonathan Colasanti is often cited by papers focused on HIV/AIDS Research and Interventions (47 papers), HIV, Drug Use, Sexual Risk (37 papers) and Opioid Use Disorder Treatment (16 papers). Jonathan Colasanti collaborates with scholars based in United States, Canada and Nigeria. Jonathan Colasanti's co-authors include Wendy S. Armstrong, Carlos del Rı́o, Allison L. Agwu, Mamta K. Jain, Tulika Singh, Michael A. Horberg, Melanie Thompson, William R. Short, Judith A. Aberg and Minh Ly Nguyen and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Clinical Infectious Diseases.

In The Last Decade

Jonathan Colasanti

63 papers receiving 881 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jonathan Colasanti United States 15 614 475 198 195 152 69 897
Meg Sullivan United States 16 610 1.0× 519 1.1× 137 0.7× 282 1.4× 81 0.5× 37 812
Alan R. Lifson United States 20 631 1.0× 430 0.9× 182 0.9× 398 2.0× 79 0.5× 42 1.2k
Ellen Eaton United States 11 517 0.8× 362 0.8× 227 1.1× 97 0.5× 200 1.3× 73 823
S Clarke Ireland 20 617 1.0× 428 0.9× 198 1.0× 53 0.3× 60 0.4× 45 976
Julie Alperen United States 11 251 0.4× 369 0.8× 68 0.3× 141 0.7× 212 1.4× 11 591
Hansel Tookes United States 19 355 0.6× 751 1.6× 55 0.3× 162 0.8× 518 3.4× 73 956
Monica Katyal United States 9 334 0.5× 211 0.4× 115 0.6× 167 0.9× 126 0.8× 18 567
Dita Broz United States 22 818 1.3× 1.1k 2.3× 122 0.6× 264 1.4× 368 2.4× 54 1.4k
Katherine Davenny United States 10 616 1.0× 914 1.9× 257 1.3× 134 0.7× 236 1.6× 14 1.2k
Justin S. Routman United States 5 784 1.3× 551 1.2× 241 1.2× 228 1.2× 26 0.2× 9 866

Countries citing papers authored by Jonathan Colasanti

Since Specialization
Citations

This map shows the geographic impact of Jonathan Colasanti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathan Colasanti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathan Colasanti more than expected).

Fields of papers citing papers by Jonathan Colasanti

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jonathan Colasanti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathan Colasanti. The network helps show where Jonathan Colasanti may publish in the future.

Co-authorship network of co-authors of Jonathan Colasanti

This figure shows the co-authorship network connecting the top 25 collaborators of Jonathan Colasanti. A scholar is included among the top collaborators of Jonathan Colasanti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jonathan Colasanti. Jonathan Colasanti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Davy-Méndez, Thibaut, Sonia Napravnik, Brenna Hogan, et al.. (2025). Changes in the Prevalence of Non-AIDS Conditions Among Hospitalized Persons With HIV in the United States and Canada, 2008–2018. Clinical Infectious Diseases. 81(4). 806–814.
2.
Feaster, Daniel J., Lauren Gooden, Yue Pan, et al.. (2025). Project RETAIN: Providing Integrated Care for People With HIV Who Use Cocaine. Open Forum Infectious Diseases. 12(4). ofaf104–ofaf104. 1 indexed citations
3.
Colasanti, Jonathan, Victoria Robinson, Erica Anderson, et al.. (2025). Long-Acting Cabotegravir/Rilpivirine, Lenacapavir, and Ibalizumab Use Among Persons With HIV-1 Viremia at a Ryan White-Funded Clinic in the Urban US South. Clinical Infectious Diseases.
4.
Christopoulos, Katerina, M. Smith, Ryan W. Walker, et al.. (2024). Learning from the first: a qualitative study of the psychosocial benefits and treatment burdens of long‐acting cabotegravir/rilpivirine among early adopters in three U.S. clinics. Journal of the International AIDS Society. 27(11). e26394–e26394. 5 indexed citations
5.
Collins, Lauren F., Kimberly A. Koester, Moira McNulty, et al.. (2024). Patient Attitudes Toward Self- or Partner-, Friend-, or Family-Administered Long-acting Injectable Antiretroviral Therapy: A Mixed-Methods Study Across 3 Urban Human Immunodeficiency Virus Clinics. Open Forum Infectious Diseases. 11(6). ofae265–ofae265. 4 indexed citations
6.
Fujita, Ayako, C Christina Mehta, Oyindamola B. Yusuf, et al.. (2024). Co-Utilization of HIV, Substance Use, Mental Health Services Among Women With Current Substance Use: Opportunities for Integrated Care?. Journal of Primary Care & Community Health. 15. 4287905691–4287905691. 3 indexed citations
7.
Damhorst, Gregory L., Eric C. Fitts, Julie Sullivan, et al.. (2024). Performance of the Xpert™ Mpox PCR assay with oropharyngeal, anorectal, and cutaneous lesion swab specimens. Journal of Clinical Virology. 171. 105659–105659. 6 indexed citations
8.
Marcus, Julia L., Colleen F. Kelley, Allison L. Agwu, et al.. (2024). Policy Recommendations to Support Equitable Access to Long-Acting Injectables for HIV Prevention and Treatment: A Policy Paper of the Infectious Diseases Society of America and the HIV Medicine Association. Clinical Infectious Diseases. 82(2). 206–211. 4 indexed citations
9.
Koester, Kimberly A., Moira McNulty, Jonathan Colasanti, et al.. (2024). Acceptability of Long-Acting Injectable Antiretroviral Therapy Among People with HIV Receiving Care at Three Ryan White Funded Clinics in the United States. AIDS and Behavior. 28(7). 2226–2238. 6 indexed citations
10.
Koester, Kimberly A., Jonathan Colasanti, Moira McNulty, et al.. (2023). Assessing readiness to implement long-acting injectable HIV antiretroviral therapy: provider and staff perspectives. SHILAP Revista de lepidopterología. 4(1). 128–128. 9 indexed citations
11.
Marseille, Elliot, Ryan W. Walker, Jon Oskarsson, et al.. (2023). 1585. The Annual Cost per Newly Virally-Suppressed Person with HIV in Those Starting Long-Acting Injectable Antiretroviral Therapy with Detectable Viremia in a Safety-Net Clinic in San Francisco. Open Forum Infectious Diseases. 10(Supplement_2). 1 indexed citations
12.
Rebolledo, Paulina A., Boghuma K Titanji, Sheetal Kandiah, et al.. (2023). Utility of a Viral Vesicular Panel Multiplex Polymerase Chain Reaction Assay for the Diagnosis of Monkeypox, Herpes Simplex, and Varicella Zoster Viruses. Open Forum Infectious Diseases. 10(3). ofad140–ofad140. 5 indexed citations
13.
Farber, Eugene W., Jeri Sumitani, Kirk A. Easley, et al.. (2023). The CARES Program: Improving Viral Suppression and Retention in Care Through a Comprehensive Team-Based Approach to Care for People with HIV and Complex Psychosocial Needs. AIDS Patient Care and STDs. 37(8). 416–424. 3 indexed citations
14.
Summers, Nathan A., Jonathan Colasanti, Daniel J. Feaster, et al.. (2020). Predictors for Poor Linkage to Care Among Hospitalized Persons Living with HIV and Co-Occurring Substance Use Disorder. AIDS Research and Human Retroviruses. 36(5). 406–414. 16 indexed citations
15.
Colasanti, Jonathan, et al.. (2020). Improving Outpatient Management of Patients On Chronic Opioid Therapy. Infectious Disease Clinics of North America. 34(3). 621–635. 2 indexed citations
16.
Hussen, Sophia A., et al.. (2020). Mental Health Service Utilization Among Young Black Gay, Bisexual, and Other Men Who Have Sex with Men in HIV Care: A Retrospective Cohort Study. AIDS Patient Care and STDs. 35(1). 9–14. 13 indexed citations
18.
Colasanti, Jonathan, et al.. (2016). The Perilous Road from HIV Diagnosis in the Hospital to Viral Suppression in the Outpatient Clinic. AIDS Research and Human Retroviruses. 32(8). 729–736. 6 indexed citations
19.
Colasanti, Jonathan, Jane Kelly, Yi‐Juan Hu, et al.. (2015). Continuous Retention and Viral Suppression Provide Further Insights Into the HIV Care Continuum Compared to the Cross-sectional HIV Care Cascade. Clinical Infectious Diseases. 62(5). 648–654. 100 indexed citations
20.
Colasanti, Jonathan, et al.. (2012). Disparities in HIV-treatment Responses between Haitians, African Americans, and Hispanics Living in Miami-Dade County, Florida. Journal of Health Care for the Poor and Underserved. 23(1). 179–190. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026